Navigation Links
AstraZeneca and Rigel Sign Worldwide License Agreement for a Potential New Treatment for Chronic Asthma
Date:6/19/2012

g anti-rheumatic drugs (DMARDs) and parenteral anti-TNFs.

About Rigel (www.rigel.com)
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis with its partner AstraZeneca; R343, an inhaled SYK inhibitor that has completed Phase 1 clinical trials for asthma; R333, a topical JAK/SYK inhibitor for discoid lupus; and R548, an oral JAK3 inhibitor for the treatment of transplant rejection and other immune disorders.

About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.

Rigel Forward-Looking Statements
This press release contains "forward-looking" statements, including, without limitation, statements related to potential up-front and milestone payments and royalties that may be payable to Rigel, the potential uses, commercialization, treatment scope and efficacy of R256 and Rigel's other product candidates, Rigel's future product candidate pipeline and strategy, and the timing and d
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Covington Advises AstraZeneca in $1.26 Billion Acquisition of Ardea Biosciences
2. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
3. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
4. Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
5. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
6. ResearchMoz: Oxygen Concentrator Market Shares, Strategies and Forecasts, Worldwide, 2012 to 2018
7. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
8. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
9. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
10. ReproCELL Licensed Commercialization Right on Human iPS Cell Derived Hepatocytes - Expected Launch in Q2 2012
11. HistoRx Licenses Melanoma Assay from Yale University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CANTON, Mass. and NEW ORLEANS ... commercial leader in the field of regenerative medicine, presented ... expert economists from Analysis Group (a leading health economics ... that diabetic foot ulcers (DFU) and venous leg ulcers ... The results of this research, which reveal annual ...
(Date:5/22/2013)... 2013 Mold remediation could take a toll ... is a way to cut down the process' expense. And ... post the details of a method how to kill ... could be prevented, My Cleaning Products said. But in case ... a mold remediation must then be promptly implemented as it ...
(Date:5/22/2013)... May 22, 2013 A recent study from ... on athletes to find that those who took probiotics were ... results from the study showed that in extreme heat conditions, ... for their adult acne treatment explains what this ... it may help their skin condition. , While researchers ...
(Date:5/21/2013)... , May 21, 2013  On May 9, ... ), the global business advisory firm dedicated to ... (the "Company"), announced that it has combined the ... formerly included within the Corporate Finance/Restructuring segment with ... to form a single integrated practice whose financial ...
Breaking Biology Technology:Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,ONTY) (TSX: ONY) (the "Company") ... per basic and diluted share for the quarter ended ... basic and diluted share for the,comparable period in 2007. ... was $2.0 million in the first quarter of 2008, ...
... PITTSBURGH, May 7 Mylan Inc. (NYSE: MYL ... approval,from the U.S. Food and Drug Administration (FDA) for ... 0.25 mg,(base), 0.5 mg (base), 1 mg (base), 2 ... mg (base)., Ropinirole Hydrochloride Tablets are the generic ...
... $17 ... Million, TUCSON, Ariz., ... it has signed a letter of intent in,which Microbix Biosystems will acquire ... is an FDA-approved,thrombolytic, or clot-dissolving agent, indicated for the treatment of,acute massive ...
Cached Biology Technology:Oncothyreon Reports First Quarter 2008 Financial Results 2Oncothyreon Reports First Quarter 2008 Financial Results 3Oncothyreon Reports First Quarter 2008 Financial Results 4Oncothyreon Reports First Quarter 2008 Financial Results 5ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 2ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 3ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase 4
(Date:5/21/2013)... for a long time that some creatures evolve more ... for plants. But it may be that height plays ... and the U. S. National Evolutionary Synthesis Center. ... in the journal Nature Communications , Lanfear and ... Drawing from a database of global patterns in plant ...
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
(Date:5/21/2013)... ANN ARBORThe new University of Michigan Water Center ... to support Great Lakes restoration and protection efforts. ... will support diverse projects, including efforts to track ... effectiveness of techniques to control non-native weedy plant ... and monitor fish responses to restoration activities. , ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Keeping stem cells strong 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
... January 18, 2011 Using chemical compounds found in a ... ultraviolet light, a Scripps Research Institute team has created a ... biomedical potential. Already, one of the compounds has shown great ... With the report of their work scheduled to ...
... Soy protein,s ability to lower total and ... been extensively studied, but the mechanism whereby soy ... published in the Journal of Clinical Lipidology ... total cholesterol and non-HDL (non-high-density lipoprotein) cholesterol significantly ...
... EAST LANSING, Mich. The downsides of China,s explosive ... now are joined by an upside: Better environmental citizens. ... and leadership when considering environmental behavior in China,s cities. ... Environmental Conservation , scientists at the Center for ...
Cached Biology News:Scripps Research team creates new synthetic compound with HIV-fighting promise 2Scripps Research team creates new synthetic compound with HIV-fighting promise 3New study shows soy protein lowers non-HDL cholesterol significantly more than milk protein 2Big city life may make residents lean toward green, study says 2
Cytofix/Cytoperm Kit 250 Tests...
Cytofix/Cytoperm Plus Kit with GolgiPlug 250 Tests...
Complete PCR kit. Includes: MasterAmp™ Taq DNA Polymerase, 10X PCR Buffer, MasterAmp™ 10X PCR Enhancer, dNTP Mix, 2.5 mM each, 25 mM MgCl2, Enzyme Dilution Buffer, Control Template and Prim...
Mouse monoclonal to OCIL ( Abpromise for all tested applications)....
Biology Products: